Northwire Canada EditionSunday, July 26, 2026
Northwire
B 0.150 +0.0% IFOS 2.28 −2.6% IMM 0.060 +0.0% ROCK 3.38 −1.7% NVX 0.250 −7.4% HAR 0.050 +0.0% YGT 0.175 +0.0% GEN 0.070 −nan% CRB 0.040 +14.3% MSA 7.07 +2.2% AEM 204.81 +0.7% OPW 0.105 +5.0% GRL 0.275 −1.8% AIS 0.150 +0.0% CUU 0.580 −1.7% SOMA 0.720 +5.9% B 0.150 +0.0% IFOS 2.28 −2.6% IMM 0.060 +0.0% ROCK 3.38 −1.7% NVX 0.250 −7.4% HAR 0.050 +0.0% YGT 0.175 +0.0% GEN 0.070 −nan% CRB 0.040 +14.3% MSA 7.07 +2.2% AEM 204.81 +0.7% OPW 0.105 +5.0% GRL 0.275 −1.8% AIS 0.150 +0.0% CUU 0.580 −1.7% SOMA 0.720 +5.9%
Financings

Oracle Commodity closes $280,000 private placement

ORCL · Price

Executive Summary

  • Oracle Commodity Holding Corp. has closed a non-brokered private placement of 8 million units, raising $280,000 in gross proceeds.
  • The transaction involves insider participation, with a director and officer subscribing for 1.75 million units ($61,250), constituting a related-party transaction under Multilateral Instrument 61-101.
  • Proceeds are designated for working capital and general corporate purposes, with specific restrictions on using funds for the pending acquisition of a royalty from U.S. Fluorspar LLC until TSX Venture Exchange approval is granted.

Key Details

  • Transaction Structure: Non-brokered private placement of 8,000,000 units.
  • Price: 3.5 cents per unit.
  • Gross Proceeds: $280,000.
  • Unit Composition: Each unit consists of one common share and one common share purchase warrant.
  • Warrant Terms: Each warrant allows the purchase of one additional share at an exercise price of 6 cents per share for a period of three years from issuance.
  • Insider Participation: A director and officer subscribed for 1,750,000 units for gross proceeds of $61,250.
  • Regulatory Exemptions: The company relies on exemptions from formal valuation and minority shareholder approval requirements under sections 5.5(a) and 5.7(1)(a) of MI 61-101, as the fair market value of securities issued to insiders does not exceed 25% of the company's market capitalization.
  • Use of Proceeds: Working capital and general corporate purposes.
  • Hold Period: Securities are subject to a regulatory four-month-and-one-day hold period.
  • Finders' Fees: None paid.
  • Restrictions on Proceeds: No proceeds will be used for the cash consideration of the acquisition of a 2% royalty from U.S. Fluorspar LLC until TSX Venture Exchange approval is obtained. No proceeds will be paid to non-arm's-length parties or for investor relations activities, nor for any specific use representing 10% or more of gross proceeds.

Notable Quotes

  • None provided in the text.
Read the original news release →

More from Oracle Commodity Holding Corp.